Dr Tiina Lantto obtained her PhD degree in pharmaceutical biology from the Faculty of Pharmacy, University of Helsinki, Finland. Her PhD thesis focused on in vitro cytotoxicity and molecular mechanisms of plant phenolics in cell death. Before doctoral studies, Tiina obtained her MSc degree in animal biotechnology with major subjects in gene technology and molecular biology.
Prior to joining Penman Consulting, Tiina worked almost 2.5 years in the European Chemicals Agency (ECHA), where she conducted compliance checks for human toxicology endpoints, and acted as a researcher and project manager in the ECHA project with several external collaborators developing a new approach to use mammalian toxicokinetic data in bioaccumulation assessment. At ECHA, she also participated in the preparation of SVHC dossiers, the PBT Guidance update, and the work of the ECHA PBT Expert Group. Before joining ECHA, Tiina worked as a university teacher, researcher, and entrepreneur.
In Penman Consulting, Tiina works as a toxicologist managing client projects, and contributing on scientific regulatory aspects of chemical substances. Her major interests include different chemical risk assessment and management approaches worldwide, collaborative relations between chemicals regulatory authorities and industry, and the reduction of animal testing in a regulatory context, including the use of alternative methods.